Variability of ferritin measurements in chronic kidney disease; implications for iron management

被引:47
|
作者
Ford, Bradley A. [1 ]
Coyne, Daniel W. [2 ]
Eby, Charles S. [1 ,2 ]
Scott, Mitchell G. [1 ]
机构
[1] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Dept Med, St Louis, MO 63110 USA
关键词
ferritin; iron; hemodialysis; anemia; ANEMIC HEMODIALYSIS-PATIENTS; HIGH SERUM FERRITIN; INTRAVENOUS IRON; TRANSFERRIN SATURATION; DIALYSIS PATIENTS; IV IRON; DEFICIENCY; GLUCONATE; TRIAL; REDUCTION;
D O I
10.1038/ki.2008.526
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Serum ferritin levels are a proxy measure of iron stores; existing guidelines for managing anemia in hemodialysis patients suggest that serum ferritin concentrations should be maintained at > 200 ng/ml. The KDOQI recommendations further state there is insufficient evidence advocating routine intravenous iron when ferritin levels exceed 500 ng/ml. Here we determined the interassay differences and short-term intraindividual variability of serum ferritin measurements in patients on chronic hemodialysis to illustrate how these variances may affect treatment decisions. Intermethod variations of up to 150 ng/ml were found comparing six commonly used ferritin assays that evaluated thirteen pools of serum from hemodialysis and nonhemodialysis patients. The intraindividual variability for ferritin in 60 stable hemodialysis patients ranged between 2-62% measured over an initial two-week period and from 3-52% when factored over a six-week period. Our results suggests that single serum ferritin values should not be used to guide clinical decisions regarding treatment of chronic hemodialysis patients with intravenous iron due to significant analytical and intraindividual variability.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 50 条
  • [41] Just the FAQs: Frequently asked questions about iron and anemia in patients with chronic kidney disease
    Van Wyck, DB
    Bailie, G
    Aronoff, G
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) : 426 - 432
  • [42] Association of Markers of Iron Stores with Outcomes in Patients with Nondialysis-Dependent Chronic Kidney Disease
    Kovesdy, Csaba P.
    Estrada, Wilber
    Ahmadzadeh, Shahram
    Kalantar-Zadeh, Kamyar
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (02): : 435 - 441
  • [43] The effects of oral iron supplementation on the progression of anemia and renal dysfunction in patients with chronic kidney disease
    Kim, S. M.
    Lee, C. -H.
    Oh, Y. K.
    Joo, K. W.
    Kim, Y. S.
    Kim, S.
    Lim, C. S.
    CLINICAL NEPHROLOGY, 2011, 75 (05) : 472 - 479
  • [44] Iron and Clinical Outcomes in Dialysis and Non-Dialysis-Dependent Chronic Kidney Disease Patients
    Kovesdy, Csaba P.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2009, 16 (02) : 109 - 116
  • [45] Anemia management in chronic kidney disease
    Fishbane, Steven
    Nissenson, Allen R.
    KIDNEY INTERNATIONAL, 2010, 78 : S3 - S9
  • [46] Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?
    Wish, Jay B.
    Aronoff, George R.
    Bacon, Bruce R.
    Brugnara, Carlo
    Eckardt, Kai-Uwe
    Ganz, Tomas
    Macdougall, Iain C.
    Nunez, Julio
    Perahia, Adam J.
    Wood, John C.
    AMERICAN JOURNAL OF NEPHROLOGY, 2018, 47 (02) : 72 - 83
  • [47] Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease
    Ganz, Tomas
    Locatelli, Francesco
    Arici, Mustafa
    Akizawa, Tadao
    Reusch, Michael
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [48] Response to oral iron therapy in children with anemia of chronic kidney disease
    Kelly Meza
    Sharmi Biswas
    Chantal Talmor
    Kanza Baqai
    Dmitry Samsonov
    Sonia Solomon
    Oleh Akchurin
    Pediatric Nephrology, 2024, 39 : 233 - 242
  • [49] Hepcidin-a well-known iron biomarker with prognostic implications in chronic kidney disease
    Wagner, Martin
    Ashby, Damien
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (12) : 2936 - 2939
  • [50] Anemia of Chronic Kidney Disease-A Narrative Review of Its Pathophysiology, Diagnosis, and Management
    Badura, Krzysztof
    Janc, Jedrzej
    Wasik, Joanna
    Gnitecki, Szymon
    Skwira, Sylwia
    Mlynarska, Ewelina
    Rysz, Jacek
    Franczyk, Beata
    BIOMEDICINES, 2024, 12 (06)